Taurine crosses the [[blood–brain barrier]]<ref>{{cite journal|last1=Urquhart|first1=N|last2=Perry|first2=TL|last3=Hansen|first3=S|last4=Kennedy|first4=J|year=1974|title=Passage of taurine into adult mammalian brain|url=|journal=Journal of Neurochemistry|volume=22|issue=5|pages=871–2|doi=10.1111/j.1471-4159.1974.tb04309.x|pmid=4407108}}</ref><ref>{{cite journal|last1=Tsuji|first1=A|last2=Tamai|first2=I|year=1996|title=Sodium- and chloride-dependent transport of taurine at the blood–brain barrier|url=|journal=Advances in Experimental Medicine and Biology|volume=403|issue=|pages=385–91|pmid=8915375|doi=10.1007/978-1-4899-0182-8_41|series=Advances in Experimental Medicine and Biology|isbn=978-1-4899-0184-2}}</ref><ref>{{cite journal|last1=Salimäki|first1=J|last2=Scriba|first2=G|last3=Piepponen|first3=TP|last4=Rautolahti|first4=N|last5=Ahtee|first5=L|year=2003|title=The effects of systemically administered taurine and N-pivaloyltaurine on striatal extracellular dopamine and taurine in freely moving rats|url=|journal=Naunyn-Schmiedeberg's Archives of Pharmacology|volume=368|issue=2|pages=134–41|doi=10.1007/s00210-003-0776-6}}</ref> and has been implicated in a wide array of physiological phenomena including inhibitory [[neurotransmission]],<ref>{{cite journal|last1=Olive|first1=MF|year=2002|title=Interactions between taurine and ethanol in the central nervous system|url=|journal=Amino Acids|volume=23|issue=4|pages=345–57|doi=10.1007/s00726-002-0203-1|pmid=12436202}}</ref> [[long-term potentiation]] in the [[striatum]]/[[hippocampus]],<ref>{{cite journal|last1=Dominy|first1=J Jr|last2=Thinschmidt|first2=JS|last3=Peris|first3=J|last4=Dawson|first4=R Jr|last5=Papke|first5=RL|year=2004|title=Taurine-induced long-lasting potentiation in the rat hippocampus shows a partial dissociation from total hippocampal taurine content and independence from activation of known taurine transporters|url=|journal=Journal of Neurochemistry|volume=89|issue=5|pages=1195–205|pmid=15147512|doi=10.1111/j.1471-4159.2004.02410.x}}</ref> [[Membrane stabilizing effect|membrane stabilization]],<ref>{{cite journal|last=Birdsall|first=TC|title=Therapeutic applications of taurine|journal=Alternative Medicine Review|year=1998|volume=3|issue=2|pages=128–36|pmid=9577248}}</ref> feedback inhibition of [[neutrophil]]/[[macrophage]] [[respiratory burst]], [[adipose]] tissue regulation and possible prevention of obesity,<ref>Ide T, Kushiro M, Takahashi Y, Shinohara K, Cha S. "mRNA expression of enzymes involved in taurine biosynthesis in rat adipose tissues. Metabolism: Clinical and Experimental 2002 Sep;51(9):1191-7.</ref><ref>{{cite journal|last1=Tsuboyama-Kasaoka|first1=N|last2=Shozawa|first2=C|last3=Sano|first3=K|last4=Kamei|first4=Y|last5=Kasaoka|first5=S|last6=Hosokawa|first6=Y|last7=Ezaki|first7=O|year=2006|title=Taurine (2-aminoethanesulfonic acid) deficiency creates a vicious circle promoting obesity|url=|journal=Endocrinology|volume=147|issue=7|pages=3276–84|pmid=16627576|doi=10.1210/en.2005-1007}}</ref> calcium [[homeostasis]],<ref>{{cite journal|last1=Foos|first1=TM|last2=Wu|first2=JY|year=2002|title=The role of taurine in the central nervous system and the modulation of intracellular calcium homeostasis|url=|journal=Neurochemical Research|volume=27|issue=1–2|pages=21–6|doi=10.1023/A:1014890219513|pmid=11926272}}</ref> recovery from [[osmotic shock]],<ref>{{cite journal|vauthors=Stummer W, Betz AL, Shakui P, Keep RF |title=Blood–brain barrier taurine transport during osmotic stress and in focal cerebral ischemia|journal=Journal of Cerebral Blood Flow and Metabolism|year=1995|volume=15|issue=5|pages=852–9|doi=10.1038/jcbfm.1995.106|pmid=7673378}}</ref> protection against glutamate [[excitotoxicity]]<ref>{{cite journal|vauthors=Leon R, Wu H, Jin Y, Wei J, Buddhala C, Prentice H, Wu JY |title=Protective function of taurine in glutamate-induced apoptosis in cultured neurons|journal=Journal of Neuroscience Research|volume=87|issue=5|pages=1185–1194|year=2008|pmid=|doi=10.1002/jnr.21926 |url=}}</ref> and prevention of epileptic seizures.<ref>{{cite journal|author=El Idrissi A, Messing J, Scalia J, Trenkner E|title=Prevention of epileptic seizures by taurine|journal=Advances in Experimental Medicine and Biology|year=2003|volume=526|pages=515–25|pmid=12908638|doi=10.1007/978-1-4615-0077-3_62|url=|last2=Messing|last3=Scalia|last4=Trenkner|series=Advances in Experimental Medicine and Biology|isbn=978-1-4613-4913-6}}</ref>

 
Dietary taurine has a blood cholesterol-lowering effect in young overweight adults. Furthermore,  body weight also decreased significantly with taurine supplementation.<ref>{{cite journal|last1=Zhang|first1=M|last2=Bi|first2=LF|last3=Fang|first3=JH|last4=Su|first4=XL|last5=Da|first5=GL|last6=Kuwamori|first6=T|last7=Kagamimori|first7=S|year=2004|title=Beneficial effects of taurine on serum lipids in overweight or obese non-diabetic subjects|url=|journal=Amino Acids|volume=26|issue=3|pages=267–71|pmid=15221507|doi=10.1007/s00726-003-0059-z}}</ref> These findings are consistent with animal studies.<ref>{{cite journal|last1=Choi|first1=MJ|last2=Kim|first2=JH|last3=Chang|first3=KJ|year=2006|title=The effect of dietary taurine supplementation on plasma and liver lipid concentrations and free amino acid concentrations in rats fed a high-cholesterol diet|url=|journal=Advances in Experimental Medicine and Biology|volume=583|issue=|pages=235–42|doi=10.1007/978-0-387-33504-9_25|pmid=17153607|series=Advances in Experimental Medicine and Biology|isbn=978-0-387-32356-5}}</ref>

 
According to animal studies, taurine produces an [[anxiolytic]] effect and may act as a modulator or antianxiety agent in the central nervous system by activating the [[glycine receptor]].<ref>{{cite journal |vauthors=Kong WX, Chen SW, Li YL, etal |title=Effects of taurine on rat behaviors in three anxiety models|journal=Pharmacol. Biochem. Behav|volume=83|issue=2|pages=271–6|year=2006|pmid=16540157|doi=10.1016/j.pbb.2006.02.007}}</ref><ref>{{cite journal|last1=Zhang|first1=CG|last2=Kim|first2=SJ|title=Taurine induces anti-anxiety by activating strychnine-sensitive glycine receptor in vivo|journal=Annals of Nutrition & Metabolism|year=2007|volume=51|issue=4|pages=379–86|doi=10.1159/000107687}}</ref><ref>{{cite journal|last1=Chen|first1=SW|last2=Kong|first2=WX|last3=Zhang|first3=YJ|last4=Li|first4=YL|last5=Mi|first5=XJ|last6=Mu|first6=XS|year=2004|title=Possible anxiolytic effects of taurine in the mouse elevated plus-maze|url=|journal=Life Sciences|volume=75|issue=12|pages=1503–11|doi=10.1016/j.lfs.2004.03.010|pmid=15240184}}</ref>

 
In diabetic rats, taurine significantly decreased weight and decreased [[blood sugar]].<ref name=Nakaya2000>{{cite journal|vauthors=Nakaya Y, Minami A, Harada N, Sakamoto S, Niwa Y, Ohnaka M |title=Taurine improves insulin sensitivity in the Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous type 2 diabetes|journal=American Journal of Clinical Nutrition|volume=71|issue=1|pages=54–8|year=2000|pmid=10617946|url=http://www.ajcn.org/cgi/content/full/71/1/54}}</ref> Likewise, taurine administration to diabetic [[rabbit]]s resulted in 30% decrease in serum glucose levels.<ref>{{cite journal|vauthors=Winiarska K, Szymanski K, Gorniak P, Dudziak M, Bryla J |title=Hypoglycaemic, antioxidative and nephroprotective effects of taurine in alloxan diabetic rabbits|journal=Biochimie|volume=91|issue=2|pages=261–270|year=2008|pmid=18957317|doi=10.1016/j.biochi.2008.09.006|url=}}</ref> According to the single study on human subjects, daily administration of 1.5 g of taurine had no significant effect on insulin secretion or insulin sensitivity.<ref>C. Brøns, C. Spohr, H. Storgaard, J. Dyerberg, A. Vaag. "Effect of taurine treatment on insulin secretion and action, and on serum lipid levels in overweight men with a genetic predisposition for type II diabetes mellitus. European Journal of Clinical Nutrition (2004) 58, 1239–1247.</ref> There is evidence that taurine may exert a beneficial effect in preventing diabetes-associated [[microangiopathy]] and tubulointerstitial injury in [[diabetic nephropathy]].<ref>{{cite journal|vauthors=Wu QD, Wang JH, Fennessy F, Redmond HP, Bouchier-Hayes D |title=Taurine prevents high-glucose-induced human vascular endothelial cell apoptosis|journal=The American journal of physiology|year=1999|volume=277|issue=6 Pt 1|pages=C1229–38|pmid=10600775|doi=|url=}}</ref><ref>{{cite journal|last1=Verzola|first1=D|last2=Bertolotto|first2=MB|last3=Villaggio|first3=B|last4=Ottonello|first4=L|last5=Dallegri|first5=F|last6=Frumento|first6=G|last7=Berruti|first7=V|last8=Gandolfo|first8=MT|last9=Garibotto|first9=G|year=2002|title=Taurine prevents apoptosis induced by high ambient glucose in human tubule renal cells|url=|journal=Journal of investigative medicine: the official publication of the American Federation for Clinical Research|volume=50|issue=6|pages=443–51|doi=10.2310/6650.2002.32504|display-authors=etal}}</ref>

 
Taurine acts as a glycation inhibitor. Taurine-treated diabetic rats had a decrease in the formation of [[advanced glycation end product]]s (AGEs) and AGEs content.<ref>Effects of taurine on advanced glycosylation end products and expression of TGF-β in renal cortex of, TsingHua, 2005, http://www.shvoong.com/medicine-and-health/1599878-effects-taurine-advanced-glycosylation-end/</ref><ref>{{cite journal|vauthors=Huang JS, Chuang LY, Guh JY, Yang YL, Hsu MS |title=Effect of taurine on advanced glycation end products-induced hypertrophy in renal tubular epithelial cells|journal=[[Toxicology and Applied Pharmacology]]|volume=233|issue=2|pages=220–6|year=2008|pmid=18834896|doi=10.1016/j.taap.2008.09.002 |url=}}</ref> The [[United States Department of Agriculture]] has found a link between cataract development and lower levels of vitamin B<sub>6</sub>, folate, and taurine in the diets of the elderly.<ref>{{cite web|url=http://www.ars.usda.gov/is/ar/archive/nov03/ars1103.htm |title=ARS: 50 Years of Research for the Growing World |publisher=Ars.usda.gov |accessdate=2012-10-27}}</ref>

 
Taurine is involved in a number of crucial physiological processes. However, its role in these processes is not clearly understood and the influence of high taurine doses on these processes is uncertain. A substantial increase in the plasma concentration of growth hormone was reported in some epileptic patients during taurine tolerance testing (oral dose of 50&nbsp;mg per kg body mass per day), suggesting a potential to stimulate the hypothalamus and to modify neuroendocrine function.<ref>{{Cite journal|url=http://archneur.jamanetwork.com/article.aspx?articleid=577988|title=Effects of Taurine on Seizures and Growth Hormone Release in Epileptic Patients|author1=John Mantovani, MD|author2=Darryl C. DeVivo, MD|date=November 1979|accessdate=April 14, 2016}}</ref> A 1966 study found an indication that taurine (2 g/day) has some function in the maintenance and possibly in the induction of [[psoriasis]].<ref name=ref9/> Three later studies failed to support that finding.<ref>{{cite journal|last=Zackheim|first=Herschel S|first2=Eugene M|last2=Farber|year=1968|title=Taurine and Psoriasis|journal=The Journal of Investigative Dermatology|volume=50|number=3|pages=227–230|doi=10.1038/jid.1968.32|pmid=5644896|url=http://www.nature.com/jid/journal/v50/n3/full/jid196832a.html|accessdate=2013-11-23}}</ref><ref>{{cite journal|first=Herschel S.|last=Zackheim|title=Taurine and Diet in Psoriasis|journal=Archives of Dermatology|year=1982|volume=118|issue=12|page=961|doi=10.1001/archderm.1982.01650240005005|url=http://archderm.jamanetwork.com/article.aspx?articleid=543725|accessdate=2013-11-23}}</ref><ref>{{cite journal|first=Herschel S.|last=Zackheim|first2=Eugene M.|last2=Farber|year=1969|title=Low-Protein Diet and Psoriasis A Hospital Study|journal=Archives of Dermatology|volume=99|number=5|pages=580–586|doi=10.1001/archderm.1969.01610230072012|pmid=5780964|url=http://archderm.jamanetwork.com/article.aspx?articleid=530951|accessdate=2013-11-23}}</ref>

 
Taurine has an observed safe level of supplemental intake in normal healthy adults at up to 3&nbsp;g/day.<ref name="pmid18325648">{{cite journal | vauthors = Shao A, Hathcock JN | title = Risk assessment for the amino acids taurine, L-glutamine and L-arginine | journal = Regulatory Toxicology and Pharmacology : RTP | volume = 50 | issue = 3 | pages = 376–99 | year = 2008 | pmid = 18325648 | doi = 10.1016/j.yrtph.2008.01.004 | url = http://linkinghub.elsevier.com/retrieve/pii/S0273-2300(08)00010-X | accessdate = 2016-02-02 | quote = the newer method described as the Observed Safe Level (OSL) or Highest Observed Intake (HOI) was utilized. The OSL risk assessments indicate that based on the available published human clinical trial data, the evidence for the absence of adverse effects is strong for Tau at supplemental intakes up to 3 g/d, Gln at intakes up to 14 g/d and Arg at intakes up to 20 g/d, and these levels are identified as the respective OSLs for normal healthy adults.}}</ref> Even so, a study by the European Food Safety Authority found no adverse effects for up to 1,000&nbsp;mg of taurine per kilogram of body weight per day.<ref>[https://web.archive.org/web/20090216014217/http://efsa.europa.eu/EFSA/efsa_locale-1178620753812_1211902328128.htm "EFSA adopts opinion on two ingredients commonly used in some energy drinks"]. 12 February 2009. efsa.europa.eu.</ref>

 
A review published in 2008 found no documented reports of negative or positive health effects associated with the amount of taurine used in energy drinks, concluding, "The amounts of [[guarana]], taurine, and [[ginseng]] found in popular energy drinks are far below the amounts expected to deliver either therapeutic benefits or adverse events".<ref>{{cite journal|last1=Clauson|first1=KA|last2=Shields|first2=KM|last3=McQueen|first3=CE|last4=Persad|first4=N|title=Safety issues associated with commercially available energy drinks|publisher=|pages=e55–63; quiz e64–7|issue=3|volume=48|year=2008|journal=Journal of the American Pharmacists Association : JAPhA|pmid=18595815|doi=10.1331/JAPhA.2008.07055}}</ref>

 
Since the 2000s cosmetic compositions containing taurine have been introduced, possibly due to its [[fibrosis|antifibrotic]] properties. It has been shown to prevent the damaging effects of [[TGFB1]] to hair follicles.<ref name=Collin2006>{{cite journal|last=Collin|first=C|last2=Gautier|first2=B|last3=Gaillard|first3=O|last4=Hallegot|first4=P|last5=Chabane|first5=S|last6=Bastien|first6=P|last7=Peyron|first7=M|last8=Bouleau|first8=M|last9=Thibaut|first9=S|last10=Pruche|first10=F.|last11=Duranton|first11=A.|last12=Bernard|first12=B. A.|year=2006|title=Protective effects of taurine on human hair follicle grown in vitro|journal=International Journal of Cosmetic Science|volume=28|issue=4|pages=289–98|issn=0142-5463|pmid=18489269|doi=10.1111/j.1467-2494.2006.00334.x|quote=We showed that taurine [...] prevented TGF-β1-induced deleterious effects on hair follicle.|display-authors=8}}</ref> It also helps to maintain skin hydration.<ref>{{cite journal|vauthors=Janeke G, Siefken W, Carstensen S, Springmann G, Bleck O, Steinhart H, Höger P, Wittern KP, Wenck H, Stäb F, Sauermann G, Schreiner V, Doering T |title=Role of taurine accumulation in keratinocyte hydration|journal=The Journal of Investigative Dermatology|year=2003|volume=121|issue=2|pages=354–61|doi=10.1046/j.1523-1747.2003.12366.x|pmid=12880428}}</ref>
